ArticleFrontiers in immunology2020

Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.

Thanmayi Ranganath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.